This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Bulls Target J&J for Historic Breakout

By David Russell, reporter at OptionMonster

NEW YORK -- A long-term investor expects Johnson & Johnson (JNJ) to start making new highs.

The pharmaceutical and medical-supply giant has been trapped below $70 for most of the last decade, but Thursday OptionMonster's ttracking systems detected the purchase of block of 7,400 January 2015 80 calls for $1.35. Open interest in the strike was just five contracts at the beginning of the day, so this is clearly fresh buying.

Calls lock in the price investors must pay for the stock, so they can generate some nice leverage in the event of a rally. If it doesn't climb, however, these options will expire worthless.

Johnson & Johnson rose 0.44% to $68.90. It rallied sharply in June and has been consolidating in a range since then, holding support above its 2011 highs.

That could be leading some chart watchers to believe that the stock is ready to keep running for some time. The unusual thing about Thursday's option trade was their extremely long time horizon.

Overall option volume was low for the name at just 17,129 contracts, well below the 59,000 it sees in a typical session. But those 2015 calls really stood out, accounting for more than 40% of the total.

Russell has no positions in JNJ.
This commentary comes from an independent investor or market observer as part of TheStreet guest contributor program. The views expressed are those of the author and do not necessarily represent the views of TheStreet or its management.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.99 0.00%
FB $102.01 0.00%
GOOG $682.40 0.00%
TSLA $151.04 0.00%
YHOO $27.04 0.00%


Chart of I:DJI
DOW 15,973.84 +313.66 2.00%
S&P 500 1,864.78 +35.70 1.95%
NASDAQ 4,337.5120 +70.6750 1.66%

Free Reports